Literature DB >> 33621231

Right ventricular load and contractility in HIV-associated pulmonary hypertension.

Arun Rajaratnam1,2, Sofiya Rehman2, Prerna Sharma2, Vikas K Singh2, Melissa Saul2,3, Rebecca R Vanderpool1,4, Mark T Gladwin1,2,5, Marc A Simon1,2,4,6,7, Alison Morris1,2,5.   

Abstract

BACKGROUND: People living with human immunodeficiency virus (PLWH) are at risk of developing pulmonary hypertension (PH) and right ventricular (RV) dysfunction, but understanding of the relationship of RV function to afterload (RV-PA coupling) is limited. We evaluated the clinical and hemodynamic characteristics of human immunodeficiency virus (HIV)-associated PH.
METHODS: We performed a retrospective review of patients with a diagnosis of HIV undergoing right heart catheterization (RHC) from 2000-2016 in a tertiary care center. Inclusion criteria were diagnosis of HIV, age ≥ 18 years and availability of RHC data. PH was classified as either pulmonary arterial hypertension (PAH; mean pulmonary arterial pressure [mPAP] ≥ 25mmHg with pulmonary artery wedge pressure [PAWP] ≤ 15mmHg) or pulmonary venous hypertension (PVH; mPAP ≥ 25mmHg with PAWP > 15). We collected demographics, CD4 cell count, HIV viral load, RHC and echocardiographic data. The single beat method was used to calculate RV-PA coupling from RHC.
RESULTS: Sixty-two PLWH with a clinical likelihood for PH underwent RHC. Thirty-two (52%) met PH criteria (15 with PAH, 17 with PVH). Average time from diagnosis of HIV to diagnosis of PH was 11 years. Eleven of 15 individuals with PAH were on antiretroviral therapy (ART) while all 17 patients with PVH were on ART. Compared to PLWH without PH, those with PH had an increased likelihood of having a detectable HIV viral load and lower CD4 cell counts. PLWH with PAH or PVH had increased RV afterload with normal RV contractility, and preserved RV-PA coupling.
CONCLUSION: PLWH with PH (PAH or PVH) were more likely to have a detectable HIV viral load and lower CD4 count at the time of RHC. PLWH with PAH or PVH had increased RV afterload, normal RV contractility, with preserved RV-PA coupling suggestive of an early onset, mild, and compensated form of PH. These results should be confirmed in larger studies.

Entities:  

Mesh:

Year:  2021        PMID: 33621231      PMCID: PMC7901734          DOI: 10.1371/journal.pone.0243274

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  36 in total

Review 1.  The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension.

Authors:  Anton Vonk Noordegraaf; Berend E Westerhof; Nico Westerhof
Journal:  J Am Coll Cardiol       Date:  2017-01-17       Impact factor: 24.094

Review 2.  Pulmonary arterial hypertension.

Authors:  Harrison W Farber; Joseph Loscalzo
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

3.  More on Single-Beat Estimation of Right Ventriculoarterial Coupling in Pulmonary Arterial Hypertension.

Authors:  Khodr Tello; Manuel J Richter; Jens Axmann; Martin Buhmann; Werner Seeger; Robert Naeije; Hossein Ardeschir Ghofrani; Henning Gall
Journal:  Am J Respir Crit Care Med       Date:  2018-09-15       Impact factor: 21.405

4.  Pulmonary hypertension associated with HIV infection: pulmonary vascular disease: the global perspective.

Authors:  Sharilyn Almodovar; Stefania Cicalini; Nicola Petrosillo; Sonia C Flores
Journal:  Chest       Date:  2010-06       Impact factor: 9.410

5.  Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.

Authors:  Raymond L Benza; Mardi Gomberg-Maitland; C Greg Elliott; Harrison W Farber; Aimee J Foreman; Adaani E Frost; Michael D McGoon; David J Pasta; Mona Selej; Charles D Burger; Robert P Frantz
Journal:  Chest       Date:  2019-02-14       Impact factor: 9.410

6.  Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals.

Authors:  Eric A Secemsky; Rebecca Scherzer; Elaine Nitta; Alan H B Wu; David C Lange; Steven G Deeks; Jeffrey N Martin; James Snider; Peter Ganz; Priscilla Y Hsue
Journal:  JACC Heart Fail       Date:  2015-07-08       Impact factor: 12.035

Review 7.  Cardiovascular complications in HIV management: past, present, and future.

Authors:  Judith A Aberg
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

8.  Echocardiographic assessment of pulmonary vascular resistance in pulmonary arterial hypertension.

Authors:  Vincent Roule; Fabien Labombarda; Arnaud Pellissier; Rémi Sabatier; Thérèse Lognoné; Sophie Gomes; Emmanuel Bergot; Paul Milliez; Gilles Grollier; Eric Saloux
Journal:  Cardiovasc Ultrasound       Date:  2010-06-07       Impact factor: 2.062

9.  Isolated right ventricular dysfunction in patients with human immunodeficiency virus.

Authors:  Marc A Simon; Christopher D Lacomis; M Patricia George; Cathy Kessinger; Renee Weinman; Deborah McMahon; Mark T Gladwin; Hunter C Champion; Alison Morris
Journal:  J Card Fail       Date:  2014-04-12       Impact factor: 5.712

10.  EXPRESS: Surfing the Right Ventricular Pressure Waveform: Methods to assess Global, Systolic and Diastolic RV Function from a Clinical Right Heart Catheterization.

Authors:  Rebecca R Vanderpool; Reena Puri; Alexandra Osorio; Kelly Wickstrom; Ankit Desai; Stephen Black; Joe G N Garcia; Jason Yuan; Franz Rischard
Journal:  Pulm Circ       Date:  2019-04-29       Impact factor: 3.017

View more
  3 in total

1.  Defining end-systolic pressure for single-beat estimation of right ventricle-pulmonary artery coupling: simple… but not really.

Authors:  Inderjit Singh; Hannah Oakland; Ahmed Elassal; Paul M Heerdt
Journal:  ERJ Open Res       Date:  2021-08-23

2.  Pressure-based estimation of right ventricular ejection fraction.

Authors:  Paul M Heerdt; Inderjit Singh; Ahmed Elassal; Vitaly Kheyfets; Manuel J Richter; Khodr Tello
Journal:  ESC Heart Fail       Date:  2022-02-12

3.  Mice with humanized immune system as novel models to study HIV-associated pulmonary hypertension.

Authors:  Valerie J Rodriguez-Irizarry; Alina C Schneider; Daniel Ahle; Justin M Smith; Edu B Suarez-Martinez; Ethan A Salazar; Brianyell McDaniel Mims; Fahmida Rasha; Hanna Moussa; Naima Moustaïd-Moussa; Kevin Pruitt; Marcelo Fonseca; Mauricio Henriquez; Matthias A Clauss; Matthew B Grisham; Sharilyn Almodovar
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.